论文信息 - Anti-HMGCR myopathy misdiagnosed as motor neuron disease and complicated with COVID-19 infection - 字舞流文

Anti-HMGCR myopathy misdiagnosed as motor neuron disease and complicated with COVID-19 infection

V. Sansone | C. Lunetta | A. Barp | P. Ciscato | D. Velardo

[1] E. Schiopu,et al. Complete Recovery from COVID-19 Bilateral Pneumonia in an Immunosuppressed Man with Immune-Mediated Necrotizing Myopathy , 2020, Case reports in rheumatology.

[2] V. Velayudhan,et al. COVID‐19–associated myositis with severe proximal and bulbar weakness , 2020, Muscle & nerve.

[3] D. Orsucci,et al. Neurological features of COVID-19 and their treatment: a review , 2020, Drugs in context.

[4] G. Comi,et al. Pediatric anti-HMGCR necrotizing myopathy: diagnostic challenges and literature review , 2020, Neurological Sciences.

[5] X. Mariette,et al. Myositis as a manifestation of SARS-CoV-2 , 2020, Annals of the Rheumatic Diseases.

[6] A. Amato,et al. COVID-19 and neuromuscular disorders , 2020, Neurology.

[7] Ramchandran P Bongu,et al. Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report , 2019, Journal of community hospital internal medicine perspectives.

[8] L. Christopher‐Stine,et al. Triggers of inflammatory myopathy: insights into pathogenesis. , 2018, Discovery medicine.

[9] A. Mammen,et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. , 2011, Arthritis and rheumatism.

[10] A. Pestronk,et al. Polymyositis: An overdiagnosed entity , 2004, Neurology.

[11] H. Burger,et al. Polymyositis , 2003, Neurology.